Found on pharmacist.com
Group by:
Title Date Type
Leadership Institute
Reach your full leadership potential and achieve personal and professional success with Leadership360 Institute. A variety of training formats - including in-person, small group events, virtual experiences, online group and one-to-one…
Feb 15, 2018 Landing Page
Icahn backs down on Cigna-Express Scripts deal
Wall Street Journal (08/13/18) Lombardo, Cara
After two proxy-advisory firms recommended that shareholders back the proposed merger of Cigna and Express Scripts, billionaire activist investor Carl Icahn said Monday that he has dropped his plan to solicit votes from Cigna shareholders against the $54 billion deal. Icahn, who holds a 0.56% stake…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Association between SGLT-2 inhibitors and lower extremity amputation among patients with type 2 diabetes
JAMA Internal Medicine (08/13/18) Chang, Hsien-Yen; Singh, Sonal; Mansour, Omar; et al.
New users of sodium-glucose cotransporter 2 (SGLT-2) inhibitors may have a greater risk of amputation compared with some oral treatments for type 2 diabetes, according to new research. The retrospective cohort study sought to quantify the association between the use of oral medication for type 2…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Most people who think they have a penicillin allergy are wrong. That's dangerous.
Washington Post (08/10/18) Furby, Kate
Of the millions of Americans who believe they are allergic to penicillin, experts estimate that 90% were wrongly diagnosed, were never diagnosed in the first place, or have grown out of an allergy diagnosed during childhood. Patients who claim to have a penicillin allergy typically are treated with…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Westminster Pharmaceuticals issues voluntary recall of levothyroxine and liothyronine
FDA (08/10/18)
Westminster Pharmaceuticals has announced a voluntary, nationwide recall of all lots of levothyroxine and liothyronine 15 mg, 30 mg, 60 mg, 90 mg, and 120 mg to the wholesale level. The recall is being undertaken as a precaution, as the products were made using active pharmaceutical ingredients…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Use of palliative care earlier in the disease course in the context of the opioid epidemic
Journal of the American Medical Association (08/09/18) Schenker, Yael; Merlin, Jessica S.; Quill, Timothy E.
With palliative care specialists getting involved with terminally ill patients sooner, the role of opioids needs to be reexamined. Historically, they have played a significant role in keeping hospitalized patients comfortable in the advanced stages of cancer and other disease. Increasingly, though…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Amazon, Alphabet, Microsoft and others make health data pledge
CNBC (08/13/18) Farr, Christina
Some of the world's largest technology companies have pledged to remove barriers to the adoption of technologies for health care interoperability. Though the companies—including Alphabet, Amazon, IBM, and Microsoft—may be rivals in other ways, a statement from the companies said: "We…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
The large hidden costs of Medicare's prescription drug program
New York Times (08/13/18) Frakt, Austin
Although premiums have risen little since Medicare Part D was introduced, costs for taxpayers have skyrocketed 72% from 2007 to 2016. Much of this increase is due to growing enrollment and higher drug prices, but reinsurance spending—which is not reflected in premiums—has also been…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
Emergent BioSolutions to acquire PaxVax from Cerberus Capital Management
PR Newswire (08/09/18)
Emergent BioSolutions has entered into a definitive agreement to acquire PaxVax, an independent vaccine company. PaxVax is majority owned by an affiliate of Cerberus Capital Management, while Ignition Growth Capital holds a minority stake. "We are very pleased to unite two companies with a shared…
Aug 13, 2018 Publication Pharmacy Today Daily Edition
An interview with CDER director Janet Woodcock
Regulatory Focus (08/03/2018) Brennan, Zachary
In this interview, Janet Woodcock—director of FDA's Center for Drug Evaluation and Research (CDER)—discusses recent and upcoming changes including the reorganization of CDER's Office of New Drugs (OND) and how it might reshape the way investigational medicines are evaluated. Woodcock…
Aug 13, 2018 Publication Pharmacy Today Daily Edition